Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN)

CUSIP: 83548R204

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM NEW
Shares outstanding
6,190,476
Total 13F shares
255,601
Share change
+255,601
Total reported value
$376,000
Price per share
$1.47
Number of holders
7
Value change
+$376,000
Number of buys
7

Quarterly Holders Quick Answers

What is CUSIP 83548R204?
CUSIP 83548R204 identifies SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) as of Q3 2022

As of 30 Sep 2022, Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 255,601 shares. The largest 7 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, Mariner, LLC, BlackRock Inc., TWO SIGMA SECURITIES, LLC, and Tower Research Capital LLC (TRC). This page lists 7 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.